Workflow
工业大麻
icon
Search documents
诚益通涨2.01%,成交额1.12亿元,主力资金净流入461.06万元
Xin Lang Cai Jing· 2025-12-22 07:00
资金流向方面,主力资金净流入461.06万元,特大单买入584.22万元,占比5.20%,卖出0.00元,占比 0.00%;大单买入1808.19万元,占比16.08%,卖出1931.35万元,占比17.17%。 分红方面,诚益通A股上市后累计派现8055.38万元。近三年,累计派现3960.21万元。 机构持仓方面,截止2025年9月30日,诚益通十大流通股东中,长城消费增值混合A(200006)位居第 五大流通股东,持股200.00万股,为新进股东。广发聚丰混合A(270005)位居第八大流通股东,持股 133.07万股,为新进股东。广发优势成长股票A(011425)位居第十大流通股东,持股100.79万股,为 新进股东。华夏领先股票(001042)退出十大流通股东之列。 责任编辑:小浪快报 诚益通今年以来股价涨26.38%,近5个交易日涨3.05%,近20日涨6.46%,近60日跌6.81%。 资料显示,北京诚益通控制技术集团股份有限公司位于北京市大兴区生物医药产业基地庆丰西路27号, 成立日期2003年7月22日,上市日期2015年3月19日,公司主营业务涉及提供医药、生物工业自动化控制 系统整体解决 ...
首富夫妻末路:一个暴力抗法,一个卷走10亿被抓
商业洞察· 2025-12-20 09:21
------------------------------ 以下文章来源于大猫财经Pro ,作者大猫财经猫哥 大猫财经Pro . 看懂大趋势、小案例、一起搞钱 作者:史大郎&猫哥 来源:是史大郎&大猫财经Pro 01 跑路2年后,还是被抓回来了。 12月1日,一趟从新加坡经停菲律宾到美国的航班,航空公司按照惯例,通过APIS把旅客信息报送 给菲律宾。 结果,菲律宾的系统这边亮了红灯,一名乘客的信息直接跟国际刑警的红通匹配上了。 人在新加坡上了飞机,菲律宾就布控,飞机在马尼拉落地,移民局直接就把人按下了。 菲律宾移民局通报,抓住了中国逃犯郝斌(Hao Bin),很快,人就遣返回了中国,大使馆说她" 涉案金额高达9.7亿 "。 郝斌是谁呢? 她是 深大通的实控人姜剑的妻子 ,2016年,姜剑家族靠110.52亿的资产,成为了青岛首富,而 郝斌也实控不少旗下公司。 天眼查显示,她名下关联企业有10家,现在仍有2家存续,包括一家房地产公司,而她曾是这家房 企大股东的董事长。 她为啥跑路呢? 根据菲律宾移民局的通报,她违反了《刑法》第272条"挪用资金罪",在2019年-2022年,她和 同伙挪用了合计9.7785亿 ...
诚益通涨2.09%,成交额5755.27万元,主力资金净流出99.62万元
Xin Lang Cai Jing· 2025-12-19 05:18
12月19日,诚益通盘中上涨2.09%,截至13:00,报19.05元/股,成交5755.27万元,换手率1.18%,总市 值52.02亿元。 资金流向方面,主力资金净流出99.62万元,大单买入624.62万元,占比10.85%,卖出724.24万元,占比 12.58%。 分红方面,诚益通A股上市后累计派现8055.38万元。近三年,累计派现3960.21万元。 机构持仓方面,截止2025年9月30日,诚益通十大流通股东中,长城消费增值混合A(200006)位居第 五大流通股东,持股200.00万股,为新进股东。广发聚丰混合A(270005)位居第八大流通股东,持股 133.07万股,为新进股东。广发优势成长股票A(011425)位居第十大流通股东,持股100.79万股,为 新进股东。华夏领先股票(001042)退出十大流通股东之列。 责任编辑:小浪快报 资料显示,北京诚益通控制技术集团股份有限公司位于北京市大兴区生物医药产业基地庆丰西路27号, 成立日期2003年7月22日,上市日期2015年3月19日,公司主营业务涉及提供医药、生物工业自动化控制 系统整体解决方案;康复理疗医疗器械的研发、生产和销售业务 ...
美股异动丨工业大麻股继续活跃,特朗普或将签署行政令重新归类大麻
Ge Long Hui· 2025-12-18 15:10
Group 1 - Industrial hemp stocks remain active, with Canopy Growth rising over 19%, Tilray Brands increasing by more than 16%, Aurora Cannabis up nearly 11%, and SNDL gaining close to 10% [1] - Reports indicate that Trump plans to sign an executive order on Thursday to reclassify cannabis [1]
三力士涨2.08%,成交额2837.33万元,主力资金净流入37.60万元
Xin Lang Cai Jing· 2025-12-18 02:42
Group 1 - The core viewpoint of the news is that Sanlisi's stock price has shown fluctuations, with a recent increase of 2.08% and a total market capitalization of 3.987 billion yuan [1] - As of December 10, the number of shareholders for Sanlisi is 50,000, a decrease of 0.18% from the previous period, with an average of 16,140 circulating shares per person, an increase of 0.18% [2] - The company has achieved a revenue of 714 million yuan from January to September 2025, representing a year-on-year growth of 21.75%, while the net profit attributable to shareholders decreased by 45.76% to 27.65 million yuan [2] Group 2 - Sanlisi has cumulatively distributed 463 million yuan in dividends since its A-share listing, with a total of 89.73 million yuan distributed over the past three years [3] - The company's main business involves the production and sale of various rubber V-belts and synchronous belts, with rubber V-belts accounting for 72.73% of its main business revenue [2] - Sanlisi is classified under the Shenwan industry as basic chemicals - rubber - other rubber products, and is associated with concepts such as low price, small cap, sports industry, industrial hemp, and energy storage [2]
顺灏股份(002565.SZ):S10 Labs主要为工业大麻雾化器硬件提供商
Ge Long Hui· 2025-12-18 00:56
格隆汇12月18日丨顺灏股份(002565.SZ)在投资者互动平台表示,为了抓住海外工业大麻快速发展的机 遇,公司在美国设立了子公司 E10 Labs和 S10 Labs,通过全面科学的市场研究为生产研发提供依据, 给公司工业大麻业务发展提供具有前瞻性的市场信息支持,力求逐步满足国际市场对工业大麻提取物以 及终端产品的需求。其中,E10 Labs 获准在当地开展加工制造相关业务并在美国以及全球其他合法国 家和地区开展销售的合法资格,已经推出加热不燃烧系列产品;S10 Labs主要为工业大麻雾化器硬件提 供商。 ...
顺灏股份:公司在美国设立了子公司 E10 Labs和 S10 Labs
Mei Ri Jing Ji Xin Wen· 2025-12-18 00:46
Core Viewpoint - The company is strategically positioning itself to capitalize on the growing opportunities in the industrial hemp market in the United States by establishing subsidiaries and conducting market research [1] Group 1: Company Initiatives - The company has set up two subsidiaries in the U.S., E10 Labs and S10 Labs, to leverage the rapid development of the industrial hemp sector [1] - E10 Labs has been granted the legal qualification to engage in processing and manufacturing activities locally, as well as to sell products in the U.S. and other legally compliant countries [1] - The company has launched a series of heat-not-burn products through E10 Labs, indicating its commitment to innovation in the industrial hemp space [1] Group 2: Market Research and Development - The company emphasizes the importance of comprehensive scientific market research to support production and R&D efforts, aiming to provide forward-looking market information [1] - The subsidiaries are focused on meeting the international market demand for industrial hemp extracts and end products [1] - S10 Labs primarily serves as a provider of hardware for industrial hemp vaporizers, showcasing the company's diversified approach within the industry [1]
美股异动丨工业大麻股盘前再度上涨,特朗普据报最早本周签行政命令放宽大麻类管制
Ge Long Hui· 2025-12-17 09:21
Core Viewpoint - Industrial hemp stocks have seen a pre-market surge, with notable increases in companies such as CbdMD, Canopy Growth, and Tilray Brands, driven by expectations of a forthcoming executive order from President Trump to ease cannabis regulations and recognize its medical use at the federal level [1] Group 1: Market Reactions - CbdMD shares rose nearly 14% in pre-market trading [1] - Canopy Growth shares increased by over 7% [1] - Tilray Brands shares saw an increase of nearly 2% [1] Group 2: Executive Order Expectations - President Trump is expected to sign an executive order as early as this week to relax cannabis classification regulations [1] - The order is anticipated to direct the Drug Enforcement Administration or the Department of Justice to issue final regulations reclassifying cannabis from a Schedule I substance to Schedule III [1] - The executive order may also instruct Congress to pass legislation allowing legal cannabis businesses access to major banking and financial services [1] Group 3: Healthcare Implications - The executive order could direct the Centers for Medicare & Medicaid Services to permit reimbursement for cannabidiol (CBD) products under Medicare [1]
美股异动丨工业大麻股盘前大涨,美国政府据报将大幅放宽对大麻的管制
Ge Long Hui· 2025-12-12 09:25
工业大麻股盘前大涨,Tilray Brands涨超25%,Canopy Growth涨超21%,极光大麻、SNDL涨超14%。 消息面上,美媒援引知情人士消息称,美国政府预计将推动联邦层面大幅放宽对大麻的管制,将大麻及 其衍生物的监管力度降至与部分常见处方止痛药及其他药物相同的水平。美国总统特朗普10日在白宫椭 圆形办公室与美国共和党籍众议院议长迈克·约翰逊通话时讨论了这一计划。(格隆汇) ...
工业大麻概念走强,顺灏股份涨停,特朗普考虑归类大麻为低危药物
Ge Long Hui· 2025-12-12 03:18
一位白宫官员表示,关于重新分类的最终决定尚未作出。重新分类将使购买和销售大麻变得更加容易, 大麻企业一直在游说政府推动改革,而重新分类的决定可能会减轻税负和银行服务方面的障碍。 股票频道更多独家策划、专家专栏,免费查阅>> 责任编辑:栎树 格隆汇12月12日|A股市场工业大麻概念股走强,其中,顺灏股份涨停,福安药业、蓝晓科技、金鹰股 份涨超4%,诚益通、永吉股份、晨光生物涨超3%。 有消息称特朗普预计将指示政府推进将大麻重新归类为危害较低的药物,这一举措可能成为数十年来美 国大麻政策最重大的转变之一。 知情人士称,特朗普已经与大麻行业高管、卫生与公众服务部部长小罗伯特·F·肯尼迪,以及医疗保险 与医疗补助服务中心(CMS)负责人Mehmet Oz讨论了这一想法。 ...